Fundz

Neushen Therapeutics Closes Pre-A Financing With ~$20M

PRIVATESep 29, 2022

Round Type

Funding Round

ShanghaiBiotechnologyTherapeutics

Description

NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders with dual platforms of AAV-based gene therapy and small molecule discovery, announced today the closure of ~$20 million Series pre-A financing led by LAPAM, a China based venture capital. NeuShen was founded by a group of industrial executives who have extensive global experiences in central nervous system (CNS) drug development. The new capital will be used to expand the team and catalyze in-house CNS drug discovery in both the US and China.

Quick answer

NeuShen Therapeutics raised an undisclosed amount in a Funding Round round, dated September 29, 2022. NeuShen Therapeutics is based in Shanghai, China.

How much did NeuShen Therapeutics raise?
NeuShen Therapeutics raised an undisclosed amount in a Funding Round round on September 29, 2022.
What does NeuShen Therapeutics do?
We aspire to be a leading biotechnology company focusing on neurological and psychiatric diseases.
Where is NeuShen Therapeutics based and how big is it?
NeuShen Therapeutics is based in Shanghai, China.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as NeuShen Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
  • NRG Therapeutics raised $18M (Series A) on November 9, 2022.
  • Kinimmune raised an undisclosed amount (Funding Round) on November 9, 2022.
  • Juvena Therapeutics raised $41M (Funding Round) on November 8, 2022.
  • NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
  • Zenas BioPharma raised $118M (Funding Round) on November 7, 2022.

Who to call at NeuShen Therapeutics, and when

A new round usually means NeuShen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeuShen Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeuShen Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeuShen Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeuShen Therapeutics

Location

Shanghai, China

About

We aspire to be a leading biotechnology company focusing on neurological and psychiatric diseases. We aim to find cures to serious diseases and relieve the pain of patients and their families.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeuShen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NeuShen Therapeutics's next move

See what Strategic adds

NeuShen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.